Some studies have uncovered the causal function of mitogen-activated protein kinase kinase Kinase 3 (MEKK3) and KLF2/4 in CCM pathogenesis, which is independent of TGF-β/SMAD signaling (Zhou et al., 2016). The gene discussed is KLF2; the disease is cerebral cavernous malformation.